Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pinter

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Genetics and Molecular Research : GMR|December 16, 2014
Isolation and characterization of microsatellite loci from the tick Amblyomma aureolatum (Acari: Ixodidae)M Ogrzewalska, M M Bajay, K Schwarcz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2022
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasisM Gooderham, A Pinter, L K Ferris, et al.
The British Journal of Dermatology|May 26, 2017
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III studyK Reich, A Pinter, J P Lacour, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
Clinical Immunology (Orlando, Fla.)|July 7, 2024
Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasisS Rischke, S M G Schäfer, A König, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Veterinary Parasitology|July 16, 2003
Prevalence of antibodies to Neospora caninum in dogs from Amazon, BrazilW A Cañón-Franco, D P Bergamaschi, M B Labruna, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Isolation and purification of lipoarabinomannan from urine of adults with active TBJ L Cantera, A A Rashid, L M Lillis, et al.
The British Journal of Dermatology|April 25, 2019
Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III studyD Thaçi, K Papp, D Marcoux, et al.
Dermatology and Therapy|May 30, 2024
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)A Pinter, A Costanzo, S Khattri, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Genetics and Molecular Research : GMR|December 16, 2014
Isolation and characterization of microsatellite loci from the tick Amblyomma aureolatum (Acari: Ixodidae)M Ogrzewalska, M M Bajay, K Schwarcz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 17, 2022
Long-term, durable, absolute Psoriasis Area and Severity Index and health-related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate-to-severe plaque psoriasisM Gooderham, A Pinter, L K Ferris, et al.
The British Journal of Dermatology|May 26, 2017
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III studyK Reich, A Pinter, J P Lacour, et al.
The British Journal of Dermatology|April 12, 2019
Continued treatment with secukinumab is associated with high retention or regain of responseM Augustin, D Thaci, K Eyerich, et al.
Clinical Immunology (Orlando, Fla.)|July 7, 2024
Metabolomic and lipidomic fingerprints in inflammatory skin diseases - Systemic illumination of atopic dermatitis, hidradenitis suppurativa and plaque psoriasisS Rischke, S M G Schäfer, A König, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Veterinary Parasitology|July 16, 2003
Prevalence of antibodies to Neospora caninum in dogs from Amazon, BrazilW A Cañón-Franco, D P Bergamaschi, M B Labruna, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2023
Isolation and purification of lipoarabinomannan from urine of adults with active TBJ L Cantera, A A Rashid, L M Lillis, et al.
The British Journal of Dermatology|April 25, 2019
Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III studyD Thaçi, K Papp, D Marcoux, et al.
Dermatology and Therapy|May 30, 2024
Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)A Pinter, A Costanzo, S Khattri, et al.
Pageof 13